Lourdes Mengual
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Comprehensive genome-wide association study into multiple recurrence and progression risk in non-muscle invasive bladder cancer.
Journal: Cancer genetics
Published: May 05, 2026
Digital Uromonitor® outperforms quantitative polymerase chain reaction Uromonitor and cytology for non-muscle-invasive bladder cancer surveillance: results from the 'External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the Club Urológico Español de Tratamiento Oncológico Group' (EVALUATION-CUETO) study.
Journal: BJU international
Published: April 06, 2026
Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.
Journal: Cancer cytopathology
Published: March 29, 2026
Role of Bladder EpiCheck® in Bladder cancer: from primary diagnosis to surveillance.
Journal: Journal of translational medicine
Published: March 12, 2026
Improving long-term monitoring in NMIBC: Digital Uromonitor® (dUM) as a complementary tool to cystoscopy for two-year recurrence risk stratification.
Journal: Actas urologicas espanolas
Published: February 02, 2026
Improving Long-Term Monitoring in NMIBC: Digital Uromonitor® (dUM) as a Complementary Tool to Cystoscopy for Two-Year Recurrence Risk Stratification.
Journal: Actas urologicas espanolas
Published: February 02, 2026
External validation of the Uromonitor®-version 2 urine test as a biomarker for optimisation of non-muscle-invasive bladder cancer management.
Journal: BJU international
Published: October 01, 2025
Quality Assessment of Discarded Human Kidneys Using Normothermic Perfusion.
Journal: Transplantation direct
Published: September 10, 2025
Evaluation of the INCISIVE Services in Cancer Imaging: A Feasibility Study.
Journal: Seminars in oncology nursing
Published: August 01, 2025
FGFR3 immunohistochemistry as a surrogate biomarker for FGFR3 alterations in urothelial carcinoma.
Journal: Pathology, research and practice
Published: March 20, 2025
Bladder EpiCheck clinical utility to predict BCG response in non-muscle-invasive bladder cancer.
Journal: BJU international
Published: March 06, 2025
Last Updated: 09/26/2026